We are live on ! Find out more
Axa

Axa Portfolio holdings

AUM $91.9M
1-Year Est. Return 27.41%
This Fund
S&P 500
This Quarter Est. Return
+2.56%
1 Year Est. Return
+27.41%
3 Year Est. Return
+100.68%
5 Year Est. Return
+129.89%
10 Year Est. Return
+554.73%
AUM
$23B
AUM Growth
+$654M
Cap. Flow
+$6.71M
Cap. Flow %
0.03%
Top 10 Hldgs %
15.45%
Holding
1,532
New
151
Increased
540
Reduced
484
Closed
141

Top Buys

Rank Stock Value
1
VZ icon
Verizon
VZ
+$284M
2
DB icon
Deutsche Bank
DB
+$159M
3
NSC icon
Norfolk Southern
NSC
+$108M
4
HPQ icon
HP
HPQ
+$92.2M
5
DD
Du Pont De Nemours E I
DD
+$80.9M

Top Sells

Rank Stock Value
1
LLY icon
Eli Lilly
LLY
+$161M
2
F icon
Ford
F
+$87.9M
3
WHR icon
Whirlpool
WHR
+$74M
4
PNC icon
PNC Financial Services
PNC
+$72.9M
5
EMN icon
Eastman Chemical
EMN
+$72.9M

Sector Composition

Rank Sector Weight
1 Healthcare 15.62%
2 Technology 14.22%
3 Financials 13.17%
4 Industrials 11.49%
5 Energy 8.62%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BAP icon
226
Credicorp
BAP
$29.9B
$22.2M 0.1%
167,234
-13,278
-7% -$1.66M
GHC icon
227
Graham Holdings Company
GHC
$4.94B
$22.1M 0.1%
51,853
-1,782
-3% -$727K
NI icon
228
NiSource
NI
$19.9B
$22M 0.1%
1,577,539
-2,483,609
-61% -$33.6M
WDC icon
229
Western Digital
WDC
$154B
$21.8M 0.09%
313,948
-98,283
-24% -$6.42M
TSM icon
230
TSMC
TSM
$2.17T
$21.5M 0.09%
1,073,454
-254,804
-19% -$4.56M
IWB icon
231
iShares Russell 1000 ETF
IWB
$48.7B
$21.2M 0.09%
202,355
GIS icon
232
General Mills
GIS
$19.5B
$20.9M 0.09%
403,637
-227,285
-36% -$11.3M
INVX
233
Innovex International
INVX
$2.11B
$20.8M 0.09%
185,942
+11,208
+6% +$1.16M
ECL icon
234
Ecolab
ECL
$77.2B
$20.8M 0.09%
192,882
+17,567
+10% +$1.84M
JAZZ icon
235
Jazz Pharmaceuticals
JAZZ
$16B
$20.8M 0.09%
149,996
-53,454
-26% -$8.05M
ABEV icon
236
Ambev
ABEV
$46.7B
$20.7M 0.09%
2,797,261
-188,661
-6% -$1.32M
KSS icon
237
Kohl's
KSS
$1.95B
$20.5M 0.09%
360,880
-35,608
-9% -$1.91M
BG icon
238
Bunge Global
BG
$23.5B
$20.5M 0.09%
257,290
+217,690
+550% +$17.1M
OCR
239
DELISTED
OMNICARE INC
OCR
$20.4M 0.09%
341,626
-29,654
-8% -$1.8M
SRCL
240
DELISTED
Stericycle Inc
SRCL
$20.3M 0.09%
178,986
+15,342
+9% +$1.77M
INCY icon
241
Incyte
INCY
$24.8B
$20.3M 0.09%
379,486
+36,759
+11% +$2.28M
AGN
242
DELISTED
Allergan Inc
AGN
$20.3M 0.09%
163,664
+10,067
+7% +$1.23M
PII icon
243
Polaris
PII
$3.33B
$20.2M 0.09%
144,839
-302,247
-68% -$40.8M
IPGP icon
244
IPG Photonics
IPGP
$3.19B
$19.7M 0.09%
277,652
+3,481
+1% +$245K
DAL icon
245
Delta Air Lines
DAL
$52.5B
$19.7M 0.09%
568,724
+43,224
+8% +$1.39M
IFF icon
246
International Flavors & Fragrances
IFF
$21.3B
$19.7M 0.09%
205,437
+155,237
+309% +$14M
GAP
247
The Gap Inc
GAP
$7.35B
$19.6M 0.09%
490,280
-123,480
-20% -$5M
ZBH icon
248
Zimmer Biomet
ZBH
$17.8B
$19.6M 0.09%
213,833
-1,445
-0.7% -$133K
KSU
249
DELISTED
Kansas City Southern
KSU
$19.6M 0.09%
192,000
-155,000
-45% -$16M
CNI icon
250
Canadian National Railway
CNI
$73.9B
$19.5M 0.08%
347,029
-58,471
-14% -$3.22M

Similar funds

Axa's Q1 2014 Portfolio in Review

As of Q1 2014, Axa held 1,532 positions worth $23B, up 2.9% from $22.3B the previous quarter. Its ten largest holdings account for 15% of the portfolio.

Axa's Q1 2014 filing shows 151 new, 540 increased, 484 reduced and 141 closed positions. Its largest new stake was Celanese: 949,936 shares worth $52.7M. The largest sale was Eli Lilly, an estimated $161M.

By sector, the portfolio is most concentrated in Healthcare at 16% of assets, down from 16% a quarter earlier, followed by Technology and Financials.

  • Axa's largest Q1 2014 buy was Celanese: 949,936 shares worth $52.7M.
  • Axa added most to Verizon in Q1 2014, an estimated $284M increase.
  • Axa's biggest Q1 2014 reduction was Eli Lilly, cutting an estimated $161M.
  • Axa fully exited Avon Products, Inc. in Q1 2014, selling an estimated $53.7M.
  • Axa's ten largest holdings make up 15% of its $23B portfolio in Q1 2014.
  • Axa opened 151 new positions and closed 141 in Q1 2014.
  • Axa's portfolio value rose 2.9% quarter-over-quarter to $23B.

Based on Axa's 13F filing for Q1 2014, filed 13 May 2014.